The collective voice of early phase COVID-19 vaccine trial participants: Insights for improving confidence in novel vaccines

In early 2020, adult volunteers were invited to participate in a first-in-human trial of the COVID-19 vaccine, ChAdOx1 nCoV-19, in the United Kingdom (UK) at the height of the global pandemic when there was uncertainty regarding vaccine efficacy and side-effects. We conducted a retrospective survey...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Tonia M., Hodgson, Susanne H., Emary, Katherine, Patrick-Smith, Maia, te Water Naude, Rebecca, Stuart, Arabella S. V., Henry, John, English, Marcus, Moore, Maria, Douglas, Naomi, Pollard, Andrew J., Vanderslott, Samantha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Clinical / Regulatory
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161940/
https://www.ncbi.nlm.nih.gov/pubmed/37138460
http://dx.doi.org/10.1080/21645515.2023.2203023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161940/
https://www.ncbi.nlm.nih.gov/pubmed/37138460
http://dx.doi.org/10.1080/21645515.2023.2203023

Ejemplares similares